TY - JOUR
T1 - Characteristics and Outcomes of Prolonged Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery
T2 - The Post-Cardiotomy Extracorporeal Life Support (PELS-1) Cohort Study
AU - Post-Cardiotomy Extracorporeal Life Support (PELS-1) Investigators
AU - Bunge, Jeroen J H
AU - Mariani, Silvia
AU - Meuwese, Christiaan
AU - van Bussel, Bas C T
AU - Di Mauro, Michele
AU - Wiedeman, Dominik
AU - Saeed, Diyar
AU - Pozzi, Matteo
AU - Loforte, Antonio
AU - Boeken, Udo
AU - Samalavicius, Robertas
AU - Bounader, Karl
AU - Hou, Xiaotong
AU - Buscher, Hergen
AU - Salazar, Leonardo
AU - Meyns, Bart
AU - Herr, Daniel
AU - Matteucci, Sacha
AU - Sponga, Sandro
AU - MacLaren, Graeme
AU - Russo, Claudio
AU - Formica, Francesco
AU - Sakiyalak, Pranya
AU - Fiore, Antonio
AU - Camboni, Daniele
AU - Raffa, Giuseppe Maria
AU - Diaz, Rodrigo
AU - Wang, I-Wen
AU - Jung, Jae-Seung
AU - Belohlavek, Jan
AU - Pellegrino, Vin
AU - Bianchi, Giacomo
AU - Pettinari, Matteo
AU - Barbone, Alessandro
AU - Garcia, José P
AU - Shekar, Kiran
AU - Whitman, Glenn J R
AU - Gommers, Diederik
AU - Dos Reis Miranda, Dinis
AU - Lorusso, Roberto
N1 - Publisher Copyright:
© 2024 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - OBJECTIVES: Most post-cardiotomy (PC) extracorporeal membrane oxygenation (ECMO) runs last less than 7 days. Studies on the outcomes of longer runs have provided conflicting results. This study investigates patient characteristics and short- and long-term outcomes in relation to PC ECMO duration, with a focus on prolonged (> 7 d) ECMO.DESIGN: Retrospective observational cohort study.SETTING: Thirty-four centers from 16 countries between January 2000 and December 2020.PATIENTS: Adults requiring post PC ECMO between 2000 and 2020.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: Characteristics, in-hospital, and post-discharge outcomes were compared among patients categorized by ECMO duration. Survivors and nonsurvivors were compared in the subgroup of patients with ECMO duration greater than 7 days. The primary outcome was in-hospital mortality. Two thousand twenty-one patients were included who required PC ECMO for 0-3 days ( n = 649 [32.1%]), 4-7 days ( n = 776 [38.3%]), 8-10 days ( n = 263 [13.0%]), and greater than 10 days ( n = 333 [16.5%]). There were no major differences in the investigated preoperative and procedural characteristics among ECMO duration groups. However, the longer ECMO duration category was associated with multiple complications including bleeding, acute kidney injury, arrhythmias, and sepsis. Hospital mortality followed a U-shape curve, with lowest mortality in patients with ECMO duration of 4-7 days ( n = 394, 50.8%) and highest in patients with greater than 10 days ECMO support ( n = 242, 72.7%). There was no significant difference in post-discharge survival between ECMO duration groups. In patients with ECMO duration greater than 7 days, age, comorbidities, valvular diseases, and complex procedures were associated with nonsurvival.CONCLUSIONS: Nearly 30% of PC ECMO patients were supported for greater than 7 days. In-hospital mortality increased after 7 days of support, especially in patients undergoing valvular and complex surgery, or who had complications, although the long-term post-discharge prognosis was comparable to PC ECMO patients with shorter support duration.
AB - OBJECTIVES: Most post-cardiotomy (PC) extracorporeal membrane oxygenation (ECMO) runs last less than 7 days. Studies on the outcomes of longer runs have provided conflicting results. This study investigates patient characteristics and short- and long-term outcomes in relation to PC ECMO duration, with a focus on prolonged (> 7 d) ECMO.DESIGN: Retrospective observational cohort study.SETTING: Thirty-four centers from 16 countries between January 2000 and December 2020.PATIENTS: Adults requiring post PC ECMO between 2000 and 2020.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: Characteristics, in-hospital, and post-discharge outcomes were compared among patients categorized by ECMO duration. Survivors and nonsurvivors were compared in the subgroup of patients with ECMO duration greater than 7 days. The primary outcome was in-hospital mortality. Two thousand twenty-one patients were included who required PC ECMO for 0-3 days ( n = 649 [32.1%]), 4-7 days ( n = 776 [38.3%]), 8-10 days ( n = 263 [13.0%]), and greater than 10 days ( n = 333 [16.5%]). There were no major differences in the investigated preoperative and procedural characteristics among ECMO duration groups. However, the longer ECMO duration category was associated with multiple complications including bleeding, acute kidney injury, arrhythmias, and sepsis. Hospital mortality followed a U-shape curve, with lowest mortality in patients with ECMO duration of 4-7 days ( n = 394, 50.8%) and highest in patients with greater than 10 days ECMO support ( n = 242, 72.7%). There was no significant difference in post-discharge survival between ECMO duration groups. In patients with ECMO duration greater than 7 days, age, comorbidities, valvular diseases, and complex procedures were associated with nonsurvival.CONCLUSIONS: Nearly 30% of PC ECMO patients were supported for greater than 7 days. In-hospital mortality increased after 7 days of support, especially in patients undergoing valvular and complex surgery, or who had complications, although the long-term post-discharge prognosis was comparable to PC ECMO patients with shorter support duration.
KW - Humans
KW - Extracorporeal Membrane Oxygenation/methods
KW - Male
KW - Female
KW - Retrospective Studies
KW - Middle Aged
KW - Cardiac Surgical Procedures/adverse effects
KW - Hospital Mortality
KW - Aged
KW - Time Factors
KW - Cohort Studies
UR - http://www.scopus.com/inward/record.url?scp=85199753663&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000006349
DO - 10.1097/CCM.0000000000006349
M3 - Journal article
C2 - 38856631
SN - 0090-3493
VL - 52
SP - e490-e502
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 10
ER -